Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kent W Mouw

Showing results (71-80 of 121) with videos related to

Pageof 13
Sort By:
Cancer|October 15, 2013
Second nonocular tumors among survivors of retinoblastoma treated with contemporary photon and proton radiotherapyRoshan V Sethi, Helen A Shih, Beow Y Yeap, et al.
The Journal of Clinical Investigation|August 19, 2025
Quantitative functional profiling of ERCC2 mutations deciphers cisplatin sensitivity in bladder cancerJudit Börcsök, Diyavarshini Gopaul, Daphne Devesa-Serrano, et al.
Advances in Radiation Oncology|July 18, 2022
Magnetic Resonance-Guided Prostate Stereotactic Body Radiation Therapy With Daily Online Plan Adaptation: Results of a Prospective Phase 1 Trial and Supplemental CohortJonathan E Leeman, Daniel N Cagney, Raymond H Mak, et al.
The Oncologist|February 14, 2019
High IDO1 Expression Is Associated with Poor Outcome in Patients with Anal Cancer Treated with Definitive ChemoradiotherapyDevarati Mitra, Nora K Horick, Diane G Brackett, et al.
Clinical Genitourinary Cancer|September 20, 2022
Incidence of Germline Variants in Familial Bladder Cancer and Among Patients With Cancer Predisposition SyndromesMatthew Mossanen, Amin H Nassar, Samantha M Stokes, et al.
Urologic Oncology|July 14, 2020
Impact of percent positive biopsy cores on cancer-specific mortality for patients with high-risk prostate cancerDavid D Yang, Vinayak Muralidhar, Brandon A Mahal, et al.
JCO Precision Oncology|February 19, 2021
Enrichment of FGFR3-TACC3 Fusions in Patients With Bladder Cancer Who Are Young, Asian, or Have Never SmokedAmin H Nassar, Kevin Lundgren, Mark Pomerantz, et al.
Nature Biotechnology|September 12, 2017
Analysis of somatic microsatellite indels identifies driver events in human tumorsYosef E Maruvka, Kent W Mouw, Rosa Karlic, et al.
European Urology|February 5, 2019
Impact of Immune and Stromal Infiltration on Outcomes Following Bladder-Sparing Trimodality Therapy for Muscle-Invasive Bladder CancerJason A Efstathiou, Kent W Mouw, Ewan A Gibb, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
APOBEC3A-Induced DNA Damage Drives Polymerase θ Dependency and Synthetic Lethality in CancerAbhishek Bose, Weisi Liu, Paul Yoo, et al.
Pageof 13

Showing results (71-80 of 121) with videos related to

Sort By:
Pageof 13
Cancer|October 15, 2013
Second nonocular tumors among survivors of retinoblastoma treated with contemporary photon and proton radiotherapyRoshan V Sethi, Helen A Shih, Beow Y Yeap, et al.
The Journal of Clinical Investigation|August 19, 2025
Quantitative functional profiling of ERCC2 mutations deciphers cisplatin sensitivity in bladder cancerJudit Börcsök, Diyavarshini Gopaul, Daphne Devesa-Serrano, et al.
Advances in Radiation Oncology|July 18, 2022
Magnetic Resonance-Guided Prostate Stereotactic Body Radiation Therapy With Daily Online Plan Adaptation: Results of a Prospective Phase 1 Trial and Supplemental CohortJonathan E Leeman, Daniel N Cagney, Raymond H Mak, et al.
The Oncologist|February 14, 2019
High IDO1 Expression Is Associated with Poor Outcome in Patients with Anal Cancer Treated with Definitive ChemoradiotherapyDevarati Mitra, Nora K Horick, Diane G Brackett, et al.
Clinical Genitourinary Cancer|September 20, 2022
Incidence of Germline Variants in Familial Bladder Cancer and Among Patients With Cancer Predisposition SyndromesMatthew Mossanen, Amin H Nassar, Samantha M Stokes, et al.
Urologic Oncology|July 14, 2020
Impact of percent positive biopsy cores on cancer-specific mortality for patients with high-risk prostate cancerDavid D Yang, Vinayak Muralidhar, Brandon A Mahal, et al.
JCO Precision Oncology|February 19, 2021
Enrichment of FGFR3-TACC3 Fusions in Patients With Bladder Cancer Who Are Young, Asian, or Have Never SmokedAmin H Nassar, Kevin Lundgren, Mark Pomerantz, et al.
Nature Biotechnology|September 12, 2017
Analysis of somatic microsatellite indels identifies driver events in human tumorsYosef E Maruvka, Kent W Mouw, Rosa Karlic, et al.
European Urology|February 5, 2019
Impact of Immune and Stromal Infiltration on Outcomes Following Bladder-Sparing Trimodality Therapy for Muscle-Invasive Bladder CancerJason A Efstathiou, Kent W Mouw, Ewan A Gibb, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
APOBEC3A-Induced DNA Damage Drives Polymerase θ Dependency and Synthetic Lethality in CancerAbhishek Bose, Weisi Liu, Paul Yoo, et al.
Pageof 13